An observational study in Tobacco Smoking, sponsored by NYU Langone Health. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-15.
Sponsored by NYU Langone Health · Observational
Prior research has shown that the context in which program options are presented to consumer impacts consumer choice (known as the 'decoy effect'). The aims of this study are to: (1) test whether the decoy effect can impact smokers' selection of hypothetical tobacco treatment options; (2) examine sociodemographic moderators of the decoy effect; and and (3) examine whether presenting the time and clinical effectiveness of of the different treatment options modifies the decoy effect.
The investigators will recruit and conduct a cross-sectional online survey through ResearchMatch (www.researchmatch.org) with 600 tobacco users across the country. The survey will ask participants for their preferences regarding hypothetical tobacco treatment programs. Participants will be randomized to 12 conditions (n=50 per condition). Each condition has a different combination of treatment options. The survey will also assess sociodemographics and tobacco use behaviors. All participants will be asked if they would like to receive information about the state's smoking cessation quitline. Participants who would like to receive information will be given the 1800-QUIT-NOW number and smokefree.gov website address.
NYU Langone Health is the lead sponsor of 1,391 studies on the registry; 254 are open to participants now.
Of its 227 completed or terminated interventional studies of FDA-regulated products, 191 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Participants will be recruited from ResearchMatch.org. People who are in ResearchMatch.org's database will be eligible if they are 18 years or older and self-report current tobacco use.
Exclusion Criteria:
-
Group assigned to the following answer combination: 1. 2 sessions 2. 4 sessions
Other: Online survey
Group assigned to the following answer combination: 1. 2 sessions 2. 4 sessions 3. 7 sessions
Other: Online survey
Group assigned to the following answer combination: 1. 2 sessions 2. 7 sessions
Other: Online survey
Group assigned to the following answer combination: 1. 2 sessions 2. 7 sessions 3. 10 sessions
Other: Online survey
Group assigned to the following answer combination: 1. 2 sessions (30 minutes) 2. 4 sessions (60 minutes)
Other: Online survey
Group assigned to the following answer combination: 1. 2 sessions (30 minutes) 2. 4 sessions (60 minutes) 3. 7 sessions (105 minutes)
Other: Online survey
Group assigned to the following answer combination: 1. 2 sessions (30 minutes) 2. 7 sessions (105 minutes)
Other: Online survey
Group assigned to the following answer combination: 1. 2 sessions (30 minutes) 2. 7 sessions (105 minutes) 3. 10 sessions (150 minutes)
Other: Online survey
Group assigned to the following answer combination: 1. 2 sessions (30 minutes) - 10% chance of quitting 2. 4 sessions (60 minutes) - 30% chance of quitting
Other: Online survey
Group assigned to the following answer combination: 1. 2 sessions (30 minutes) - 10% chance of quitting 2. 4 sessions (60 minutes) - 30% chance of quitting 3. 7 sessions (105 minutes) - 30% chance of quitting
Other: Online survey
Group assigned to the following answer combination: 1. 2 sessions (30 minutes) - 10% chance of quitting 2. 7 sessions (105 minutes) - 30% chance of quitting
Other: Online survey
Group assigned to the following answer combination: 1. 2 sessions (30 minutes) - 10% chance of quitting 2. 7 sessions (105 minutes) - 30% chance of quitting 3. 10 sessions (150 minutes) - 30% chance of quitting
Other: Online survey
Subjects will complete a single survey that takes 5-10 minutes to complete
Number of counseling calls chosen
Time frame: 6 months
Number of weeks until quit date chosen
Time frame: 6 months
Plan to share: No
This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
NYU Langone Health